The main objective of the Eurasian Patent Organization is to provide legal protection for inventions and industrial designs in the Contracting States on the basis of the single Eurasian patent
The EAPO will start acting as an International Searching and International Preliminary Examining Authority under the PCT from July 1, 2022
News and Press Releases
The EAPO will start acting as an International Searching and International Preliminary Examining Authority under the PCT from July 1, 2022
The Eurasian Patent Office (EAPO) informs all interested parties that from July 1, 2022, the EAPO will start operations as an International Searching Authority (ISA) and an International Preliminary Examining Authority (IPEA) under the Patent Cooperation Treaty (PCT). The decision to appoint the EAPO as an ISA and IPEA was made at the 53rd session of the Assembly of the PCT Union, which took place in October 2021.
From July 1, 2022, the amount of fees paid with respect to Eurasian applications and patents for inventions will change
The Eurasian Patent Office (EAPO) informs all interested parties that from July 1, 2022, new fees for legally significant and other actions performed in relation to Eurasian applications and patents for inventions come into force.
The EAPO Administrative Council Approved the EAPO Annual Report
The Administrative Council of the Eurasian Patent Organization (EAPO AC) under chairmanship of the plenipotentiary representative of the Republic of Tajikistan Mirzo Ismoilzoda, held its fortieth (twelfth extraordinary) session in Moscow on April 11-12, 2022.
EAPO President Grigory Ivliev Met with Chairman of Cabinet of Ministers of Kyrgyz Republic Akylbek Zhaparov
On March 22, 2022, President of the Eurasian Patent Office (EAPO) Grigory Ivliev met with Chairman of the Cabinet of Ministers and Head of the Administration of the President of the Kyrgyz Republic Akylbek Zhaparov as part of his working visit in Bishkek.
EAPO and CNIPA Agreed on Extension of PPH Program
The Eurasian Patent Office (EAPO) and the China National Intellectual Property Administration (CNIPA) agreed to continue cooperation on the Patent Prosecution Highway Program (PPH Program) for one year since April 1, 2022.
EAPO and WIPO will Help Technoparks of the Eurasian Region in the Commercialization of Intellectual Property
On March 14, 2022, President of the Eurasian Patent Office (EAPO) Grigory Ivliev and Assistant Director General of the World Intellectual Property Organization (WIPO) Marco Aleman discussed the implementation of a joint project to expand the capabilities of technology parks in the field of intellectual property commercialization in the Eurasian region.
EAPO President Met with the Head of Saudi Authority for Intellectual Property at the World Exhibition EXPO 2020 DUBAI
Grigory Ivliev stressed the intention of the Eurasian Patent Organization to develop cooperation with the member states of the Organization of Islamic Cooperation.
EAPO will Form a Common Patent Examination Environment and Develop Digital Services for Applicants
On March 3, 2022, EAPO President Grigory Ivliev took part in the opening ceremony of the Rospatent conference "Intellectual Property as an Asset of the Future" at the world exhibition EXPO 2020 DUBAI.
EAPO President Grigory Ivliev: The EAPO Pharmaceutical Register has Increased the Transparency of the Drug Market in the Eurasian Region
Exactly one year ago, on March 1, 2021, the EAPO Pharmaceutical Register, a unique database of Eurasian patents related to active pharmaceutical ingredients, was launched.
States Party to the Convention
PUBLICATION SERVER
Official publication that provides access to current descriptions of Eurasian applications and patents, including data from the initial publication, notices of changes in legal status and current claims of inventions
EAPATIS
The system provides multi-aspect search and access to the world patent Fund, including the Russian-language array of patent documentation of the Eurasian region
PHARM Reestr
Information and search resource providing information on Eurasian patents, conversion to pharmacologically active substances, their legal status in the EAPC member states, as well as on registered medicines